You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adenoviral mediated gene transfer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in Boston (Autologous, lethally irradiated melanoma cells)

Active, not recruiting
  • Melanoma
  • Autologous, lethally irradiated melanoma cells
  • Boston, Massachusetts
  • +1 more
Feb 2, 2022

Breast Cancer Trial in Boston (Autologous, Lethally Irradiated Breast Cancer Cells)

Completed
Has Results
  • Breast Cancer
  • Autologous, Lethally Irradiated Breast Cancer Cells
  • Boston, Massachusetts
  • +1 more
Mar 30, 2022

Breast Cancer Trial in Boston (Autologous, Lethally Irradiated Breast Cancer Cells)

Completed
Has Results
  • Breast Cancer
  • Autologous, Lethally Irradiated Breast Cancer Cells
  • Boston, Massachusetts
  • +1 more
Mar 30, 2022

Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Renal Cell Carcinoma Trial in Boston (GVAX)

Completed
  • Sarcoma, Clear Cell
  • +3 more
  • GVAX
  • Boston, Massachusetts
  • +1 more
Mar 2, 2021

Phenylketonuria Trial in Ankara (SAR444836)

Recruiting
  • Phenylketonuria
  • Ankara, Turkey
    Investigational Site Number: 7920001
Aug 7, 2023

Mesothelioma Trial in Philadelphia (SCH 721015)

Completed
  • Mesothelioma
  • SCH 721015
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Mar 13, 2020

Hereditary Pulmonary Alveolar Proteinosis Trial (Gene-Corrected Macrophages administered by bronchoscopic instillation)

Not yet recruiting
  • Hereditary Pulmonary Alveolar Proteinosis
  • Gene-Corrected Macrophages administered by bronchoscopic instillation
  • (no location specified)
Mar 8, 2023

Wilson Disease Trial in Spain, United States (genetic, other, drug)

Recruiting
  • Wilson Disease
  • UX701
  • +3 more
  • Los Angeles, California
  • +11 more
Jul 22, 2022

Glycogen Storage Disease Type IA Trial in Worldwide (genetic, other, drug)

Recruiting
  • Glycogen Storage Disease Type IA
  • DTX401
  • +3 more
  • Orange, California
  • +16 more
Jan 13, 2023

Cancer Trial in Philadelphia (recombinant adenovirus-hIFN-beta)

Completed
  • Cancer
  • recombinant adenovirus-hIFN-beta
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
May 12, 2020

OTC Deficiency Trial in Worldwide (genetic, other, drug)

Recruiting
  • OTC Deficiency
  • DTX301
  • +4 more
  • Aurora, Colorado
  • +19 more
Jul 29, 2022

Severe Hemophilia A Subjects Who Received BMN 270 inPrior

Enrolling by invitation
  • Hemophilia A
    • London, United Kingdom
      Royal London Hospital, Barts and the London Hemophilia Center
    Mar 13, 2023

    Hemophilia A, Gene Therapy, Clotting Disorders Trial in Johannesburg, London, Southampton (Valoctocogene Roxaparvovec)

    Recruiting
    • Hemophilia A
    • +3 more
    • Valoctocogene Roxaparvovec
    • Seoul, Korea, Republic of
    • +8 more
    Jan 6, 2023

    Severe Haemophilia A Trial in United Kingdom (valoctocogene roxaparvovec)

    Active, not recruiting
    • Severe Haemophilia A
    • valoctocogene roxaparvovec
    • Basingstoke, United Kingdom
    • +5 more
    Feb 22, 2022

    Hereditary Angioedema, HAE Trial in United States (Dose 1 of BMN 331, Dose 2 of BMN 331, Dose 3 of BMN 331)

    Recruiting
    • Hereditary Angioedema
    • HAE
    • Dose 1 of BMN 331
    • +4 more
    • Birmingham, Alabama
    • +11 more
    Jan 26, 2023

    Hemophilia A Trial in Worldwide (BAY2599023 (DTX201))

    Active, not recruiting
    • Hemophilia A
    • BAY2599023 (DTX201)
    • Little Rock, Arkansas
    • +12 more
    Jan 5, 2023

    Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

    Recruiting
    • Malignant Glioma of Brain
    • +8 more
    • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
    • Detroit, Michigan
      Henry Ford Health System
    Jan 9, 2023

    Malignant Glioma, Glioblastoma Multiforme Trial in Ann Arbor (Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L)

    Completed
    • Malignant Glioma
    • Glioblastoma Multiforme
    • Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L
    • Ann Arbor, Michigan
      University of Michigan Health System Department of Neurosurgery
    Aug 25, 2021

    Hemophilia A With Inhibitor, Hemophilia A With Anti Factor VIII Trial in United Kingdom, United States (Valoctocogene

    Recruiting
    • Hemophilia A With Inhibitor
    • Hemophilia A With Anti Factor VIII
    • Valoctocogene roxaparvovec
    • Los Angeles, California
    • +4 more
    Aug 2, 2022

    Phenylketonuria (PKU) Trial in United Kingdom, United States (BMN 307)

    Active, not recruiting
    • Phenylketonuria (PKU)
    • BMN 307
    • Tampa, Florida
    • +3 more
    Oct 6, 2021

    Liver Biopsy Following Gene Therapy For Hemophilia

    Not yet recruiting
    • Hemophilia A
    • Hemophilia B
    • Liver Biopsy
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jun 27, 2023

    GSD1 Trial in Worldwide (DTX401)

    Completed
    Has Results
    • GSD1
    • DTX401
    • steroid regimen
    • Farmington, Connecticut
    • +5 more
    Oct 25, 2022

    Ornithine Transcarbamylase (OTC) Deficiency Trial in Worldwide (scAAV8OTC, Oral prednisone)

    Completed
    Has Results
    • Ornithine Transcarbamylase (OTC) Deficiency
    • scAAV8OTC
    • +2 more
    • Aurora, Colorado
    • +8 more
    Jan 23, 2023

    DTX101 (AAVrh10FIX) in Moderate/Severe to Severe Hemophilia B

    Completed
    • Hemophilia B
      • Little Rock, Arkansas
      • +4 more
      Jan 4, 2022

      Refractory Angina Pectoris, Gene Transfer, Coronary Artery Disease Trial in Copenhagen, Kuopio (AdvVEGF-D, Control Rx)

      Recruiting
      • Refractory Angina Pectoris
      • +2 more
      • Copenhagen, Denmark
      • +1 more
      Oct 19, 2022